Guozhang Xu
SK Life Science (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Protein Degradation and Inhibitors, HIV/AIDS drug development and treatment, HER2/EGFR in Cancer Research, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Model Studies on Protein Side Chain Modification by 4-Oxo-2-nonenal(2003)106 cited
- → 4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitors(2008)89 cited
- → Carnosine Inhibits (E)-4-Hydroxy-2-nonenal-Induced Protein Cross-Linking: Structural Characterization of Carnosine−HNE Adducts1(2003)75 cited
- → Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases(2008)55 cited
- → Independent Synthesis, Solution Behavior, and Studies on the Mechanism of Formation of a Primary Amine-Derived Fluorophore Representing Cross-linking of Proteins by (E)-4-Hydroxy-2-nonenal(1999)48 cited
- → Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitors(2018)37 cited
- → Indazole-based ligands for estrogen-related receptor α as potential anti-diabetic agents(2017)36 cited
- → Rapid Cross-Linking of Proteins by 4-Ketoaldehydes and 4-Hydroxy-2-alkenals Does Not Arise from the Lysine-Derived Monoalkylpyrroles(1999)34 cited
- → Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif(2008)33 cited
- → The Biological Effects of Structural Variation at the Meta Position of the Aromatic Rings and at the End of the Alkenyl Chain in the Alkenyldiarylmethane Series of Non-Nucleoside Reverse Transcriptase Inhibitors(2001)30 cited